Αποτελέσματα Αναζήτησης
2 Αυγ 2009 · The SATURN trial involved 889 patients who had not progressed after 4 cycles of platinum-based chemotherapy. Maintenance therapy with erlotinib (150 mg/day) resulted in an increase in...
8 Μαΐ 2019 · Tarceva combinations and maintenance therapy for stage I-III, stage IV, and recurrent EGFR + NSCLC. Tarceva (erlotinib) is widely used in the management of EGFR + non-small cell lung cancer (NSCLC) and clinical studies suggests it improves survival in early stage disease, as part of initial treatment for stage IV NSCLC, as maintenance therapy ...
20 Μαΐ 2010 · We designed the phase 3, placebo-controlled Sequential Tarceva in Unresectable NSCLC (SATURN; BO18192) study to investigate the effect of erlotinib as maintenance therapy on PFS in patients with non-progressive disease following first-line platinum-doublet chemotherapy.
Tarceva User Reviews & Ratings. Tarceva has an average rating of 8.5 out of 10 from a total of 42 reviews on Drugs.com. 83% of reviewers reported a positive experience, while 11% reported a negative experience. Write a review. Reviews for Tarceva. Top reviews. Most recent. Most helpful. High rating. Low rating. Time on medication. Par...
20 Δεκ 2010 · Recently, Cappuzzo et al 50 presented data from the Sequential Tarceva in Unresectable NSCLC (SATURN) trial a double-blind, randomized, phase III study of maintenance erlotinib vs placebo following nonprogression with first-line platinum-based chemotherapy in patients with advanced NSCLC. The final results of the study found that the median OS ...
9 Ιουλ 2012 · This result, of course, does not negate that erlotinib can be beneficial for unselected patients pretreated with chemotherapy, as demonstrated by the BR.21 trial in second- or third-line therapy and by the SATURN trial (SequentiAl Tarceva in UnResectable NSCLC) as maintenance treatment. 20
20 Μαΐ 2010 · News > Medscape Medical News. Benefits of Erlotinib Maintenance in NSCLC: SATURN Results Published. Nick Mulcahy. May 20, 2010. 0. May 20, 2010 — Results from the phase 3 Sequential Tarceva in...
